Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Brochures & Literature



View Channel


Conferences | Events


publication date: Jul 22, 2021
author/source: Medical Wire & Equipment



Inactivates SARS-CoV-2 in 60 seconds

Designed and manufactured in the UK, Σ–MM™ solution rapidly kills all microorganisms, including bacteria, mycobacteria and viruses, rendering specimens safe for transport, whilst preserving and stabilizing RNA/DNA for accurate molecular analysis across diagnostic platforms.


Key Benefits

  • Inactivates SARS-CoV-2 in 60 seconds
  • Rapidly kills all microorganisms, including bacteria, mycobacteria and viruses
  • Suitable for highly infectious clinical specimens
  • DNases and RNases inactivated
  • DNA and RNA preserved for molecular testing
  • Can be used with any swab
  • Powerful reagents kill deadly pathogens quickly
  • Safe and stable for transport at ambient temperature


The Σ–MM™ device is a highly effective single step collection.  The medium disturbs and lyses lipid membranes, destroys proteins including DNase and RNase, leaving stable intact DNA or RNA.  Specimens collected into Σ–MM™ can be transported at ambient temperatures, no freezing or refrigeration is required.  Specimens can be collected using any microbiology swabs, including MWE Transwab® and all MWE Dryswab™ products.

Σ–MM™ has been on the market for a number of years and has consistently been shown to effectively eliminate infectious microorganisms from specimens.  During the pandemic, Σ–MM™ has demonstrated compatibility on numerous PCR platforms, where samples were rendered safe for handling & viral RNA was preserved, resulting in accurate diagnostic reporting.

A study was designed in cooperation with the Medical Research Council & University of Glasgow’s Centre for Virus Research to measure the inactivation of SARS-CoV-2 achieved in specimens collected using Σ–MM™.  Σ–MM™ Molecular Medium was tested for the ability to inactivate SARS- CoV-2-Gla-1 isolate.

BS EN 14476 requires that there should be a titre reduction of more than 4 log10 for virucidal suspension tests.  Σ–MM™ consistently exceeded this requirement for both the time points and concentrations used in the study.  In fact, in 1 minute of inoculation there was no detectable virus at all in 6 out of 6 samples tested.  Given that the test concentrations were higher than would be the case for clinical specimens, the study demonstrates that Σ–MM™ can be used as a safe transport system for SARS-CoV-2 specimens, offering rapid inactivation.  The results are consistent with other studies using different inactivation reagents and methods.


View Σ–MM™ Product Information

Recent news from MWE



If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners